558 results on '"Schmitz, Joy M."'
Search Results
52. Targeting white matter neuroprotection as a relapse prevention strategy for treatment of cocaine use disorder: Design of a mechanism-focused randomized clinical trial
53. Anti-saccade error rates as a measure of attentional bias in cocaine dependent subjects
54. Relationship between impulsivity and decision making in cocaine dependence
55. Working memory fMRI activation in cocaine-dependent subjects: Association with treatment response
56. Assessment of the relative reinforcement value of smoking and drinking using a multiple-choice measurement strategy
57. Prevalence and Correlates of Sex Selling and Sex Purchasing among Adults Seeking Treatment for Cocaine Use Disorder
58. The Role of Avoidance and Inflexibility in Characterizing Response to Contingency Management for Cocaine Use Disorders: A Secondary Profile Analysis
59. Prevalence of traumatic brain injury in cocaine-dependent research volunteers
60. Neural Correlates of Impulsive Aggressive Behavior in Subjects With a History of Alcohol Dependence
61. Smoking cessation in women with cardiac risk: a comparative study of two theoretically based therapies
62. Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial
63. Diffusion Tensor Imaging of Cocaine Users and Proteomic Analysis of Postmortem Brains of Subjects Reporting Cocaine Addiction Suggest White Matter Impairment in BA9 Region of Prefrontal Cortex
64. Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial
65. Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users
66. Levodopa pharmacotherapy for cocaine dependence: Choosing the optimal behavioral therapy platform
67. Substance abuser impulsivitiy decreases with a nine-month stay in a therapeutic community
68. Cocaine dependence and concurrent marijuana use: a comparison of clinical characteristics
69. Use of stimulants to treat cocaine and methamphetamine abuse
70. Cocaine-specific speed-accuracy trade-off during anti-saccade testing differentiates patients with cocaine use disorder who achieve initial abstinence during treatment
71. Drug preference in cocaine and alcohold dual-dependent patients
72. Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial
73. Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: A replication and extension study
74. Moderators of delay tolerance in treatment-seeking cocaine users
75. Safety, tolerability and efficacy of levodopa–carbidopa treatment for cocaine dependence: Two double-blind, randomized, clinical trials
76. Illusory predictors: Generalizability of findings in cocaine treatment retention research
77. Medication Compliance During a Smoking Cessation Clinical Trial: A Brief Intervention Using MEMS Feedback
78. The role of drug use outcome expectancies in substance abuse risk: An interactional-transformational model
79. The role of homework in cognitive-behavioral therapy for cocaine dependence
80. Plasma pro- and anti-inflammatory cytokines may relate to cocaine use, cognitive functioning, and depressive symptoms in cocaine use disorder
81. Objective analysis of language use in cognitive-behavioral therapy: associations with symptom change in adults with co-occurring substance use disorders and posttraumatic stress
82. Determining predictors of attrition in an outpatient substance abuse program
83. The impact of impulsivity on cocaine use and retention in treatment. (Regular article)
84. Utility of a brief assessment of opioid demand among post-discharge trauma care patients.
85. Combustible and electronic cigarette use among patients at a large academic dental school clinic
86. A meta‐analysis of tract‐based spatial statistics studies examining white matter integrity in cocaine use disorder
87. Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder
88. Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation
89. Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder.
90. Assessing attentional bias and inhibitory control in cannabis use disorder using an eye-tracking paradigm with personalized stimuli.
91. Contingency Management and Levodopa-Carbidopa for Cocaine Treatment: A Comparison of Three Behavioral Targets
92. A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Naltrexone in Outpatients With Bipolar Disorder and Alcohol Dependence
93. High-Dose Naltrexone Therapy for Cocaine-Alcohol Dependence
94. Testing the Significance of Difference in Average Rates of Change in Controlled Longitudinal Studies With High Dropout Rates
95. Using Addiction Severity Profiles to Differentiate Cocaine-Dependent Patients with and without Comorbid Major Depression
96. Relapse prevention treatment for cocaine dependence: group vs. individual format
97. “Who gets in?”: Recruitment and screening processes of outpatient substance abuse trials
98. Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients
99. Smoking Cessation in Women with Cardiac Risk
100. A menu of potential reinforcers in a methadone maintenance program
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.